Latest Strategic Placements News

Flagship Minerals has secured A$2.75 million through a strategic placement led by long-term partners, poised to accelerate feasibility and technical work at its 2.1 million ounce Isidora Gold Project in Chile.

Electro Optic Systems (ASX:EOS) has raised A$190 million through institutional and strategic placements at an 9.3% discount, alongside a planned A$25 million share purchase plan, to fund its MARSS acquisition and expand defence capabilities.

Conico Ltd has applied for two extensive exploration licences in East Greenland targeting rare earth elements and gold-PGE mineralisation, significantly boosting its strategic landholding and critical minerals exposure.

Comvita has completed a $40.5 million capital raise combining a $30 million Rights Offer and a $10.5 million Strategic Placement, welcoming Singapore’s F&N Ventures as a near 20% strategic investor.

Australian Mines has reaffirmed strong economics for its Flemington Scandium Project, highlighting a robust 28-year mine life and significant leverage to scandium price scenarios.

Dalaroo Metals has secured A$1.75 million via a strategic placement to advance maiden drilling at its Bondoukou Gold Project and expand rare earth exploration at its Blue Lagoon project in Greenland.

Delorean Corporation has launched a $2.2 million Share Purchase Plan at $0.09 per share, matching a recent strategic placement to LMS Energy. The capital raise supports construction of key bioenergy projects in South Australia and New South Wales.

AdAlta has secured A$2.5 million in a strategic placement to push its lead CAR-T therapy BZDS1901 through critical US FDA regulatory steps and establish Australian manufacturing, building on promising clinical responses in advanced mesothelioma.

Australian Mines Limited has raised $3 million through a strategic placement led by Tribeca Investment Partners to fast-track its Flemington Scandium Project from scoping to pre-feasibility study, aiming to de-risk and advance permitting.

American West Metals (ASX: AW1) has raised A$10 million through an oversubscribed institutional placement to fast-track exploration at its West Desert and Storm Copper projects, focusing on high-demand critical metals.

Cynata Therapeutics has secured A$1.5 million through an institutional placement priced at a 22.5% discount, aiming to extend its cash runway ahead of pivotal Phase 3 and Phase 2 trial results expected in May and June 2026.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) temporarily halted trading to relodge its FY25 Annual Report, revealing a $2.86 million loss driven by US market rationalisation and ongoing cost-cutting.